Joseph Breese - Sabin Vaccine Institute

Gaps
• Most partners need education on the need / value of
the vaccine
• Relative benefit of annual campaigns in countries
with substantial year-round disease is poorly
understood
• Relatively few data on the performance of vaccine
in developing country populations
• Disease burden and economic burden (or CE of
vaccine) poorly understood in many places (but
data being generated quickly)
• NRAs gaining experience with approval of influenza
vaccines